These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 36335189)

  • 41. A novel risk prediction model of pyroptosis-related genes for the prognosis and immunotherapy response of endometrial cancer.
    Liu ZS; Jing CL
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2259-2278. PubMed ID: 35442481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
    Cai Y; Cui J; Wang Z; Wu H
    Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction of the novel immune risk scoring system related to CD8
    Zhang G; Yin Z; Fang J; Wu A; Chen G; Cao K
    Cancer Cell Int; 2023 Jun; 23(1):124. PubMed ID: 37349706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 45. RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma.
    Tang J; Tian X; Min J; Hu M; Hong L
    Front Oncol; 2022; 12():957472. PubMed ID: 36091104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 47. Gene Signatures and Prognostic Value of m6A RNA Methylation Regulators in Uterine Corpus Endometrial Carcinoma.
    Feng Y; Yao C; Shen J; Zhou J
    Discov Med; 2021; 31(164):111-120. PubMed ID: 35188885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
    Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z
    World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RNA modification regulator DDC in endometrial cancer affects the tumor microenvironment and patient prognosis.
    Zhao H; Shi C; Zhao G; Liu J; Wang X; Liang J; Li F
    Sci Rep; 2023 Oct; 13(1):18057. PubMed ID: 37872211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
    DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive Analysis of ESRRA in Endometrial Cancer.
    Wang S; Huo X
    Technol Cancer Res Treat; 2021; 20():1533033821992083. PubMed ID: 33525981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
    Niu L; Wu Z
    Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
    Liu W; Sun L; Zhang J; Song W; Li M; Wang H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33782686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma.
    Chen S; Luo X; Yang B; Zhuang J; Guo J; Zhu Y; Mo J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14701-14719. PubMed ID: 37584707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.
    Liu J; Chen T; Yang M; Zhong Z; Ni S; Yang S; Shao F; Cai L; Bai J; Yu H
    Front Cell Dev Biol; 2021; 9():753004. PubMed ID: 34901000
    [No Abstract]   [Full Text] [Related]  

  • 57. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.
    Wu R; Wu C; Zhu B; Li J; Zhao W
    Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398
    [No Abstract]   [Full Text] [Related]  

  • 58. FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC.
    Chi H; Gao X; Xia Z; Yu W; Yin X; Pan Y; Peng G; Mao X; Teichmann AT; Zhang J; Tran LJ; Jiang T; Liu Y; Yang G; Wang Q
    Front Mol Biosci; 2023; 10():1200335. PubMed ID: 37275958
    [No Abstract]   [Full Text] [Related]  

  • 59. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
    Front Genet; 2022; 13():929035. PubMed ID: 36081998
    [No Abstract]   [Full Text] [Related]  

  • 60. Machine learning combined with single-cell analysis reveals predictive capacity and immunotherapy response of T cell exhaustion-associated lncRNAs in uterine corpus endometrial carcinoma.
    Jiang F; Tao Z; Zhang Y; Xie X; Bao Y; Hu Y; Ding J; Wu C
    Cell Signal; 2024 May; 117():111077. PubMed ID: 38311301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.